The concentrations of the Drosophila proteasomal and extraproteasomal polyubiquitin receptors fluctuate in a developmentally regulated fashion. This fluctuation is generated by a previously unidentified proteolytic activity. In the present paper, we describe the purification, identification and characterization of this protease (endoproteinase I). Its expression increases sharply at the L1-L2 larval stages, remains high until the second half of the L3 stage, then declines dramatically. This sharp decrease coincides precisely with the increase of polyubiquitin receptor concentrations in late L3 larvae, which suggests a tight developmental co-regulation. RNAi-induced down-regulation of endoproteinase I results in pupal lethality. Interestingly, we found a cross-talk between the 26S proteasome and this larval protease: transgenic overexpression of the in vivo target of endoproteinase I, the C-terminal half of the proteasomal polyubiquitin receptor subunit p54/Rpn10 results in transcriptional down-regulation of endoproteinase I and consequently a lower level of proteolytic elimination of the polyubiquitin receptors. Another larval protease, Jonah65A-IV, which degrades only unfolded proteins and exhibits similar cross-talk with the proteasome has also been purified and characterized. It may prevent the accumulation of polyubiquitylated proteins in larvae contrary to the low polyubiquitin receptor concentration.
The concentrations of the Drosophila proteasomal and extraproteasomal polyubiquitin receptors fluctuate in a developmentally regulated fashion. This fluctuation is generated by a previously unidentified proteolytic activity. In the present paper, we describe the purification, identification and characterization of this protease (endoproteinase I). Its expression increases sharply at the L1-L2 larval stages, remains high until the second half of the L3 stage, then declines dramatically. This sharp decrease coincides precisely with the increase of polyubiquitin receptor concentrations in late L3 larvae, which suggests a tight developmental co-regulation. RNAi-induced down-regulation of endoproteinase I results in pupal lethality. Interestingly, we found a cross-talk between the 26S proteasome and this larval protease: transgenic overexpression of the in vivo target of endoproteinase I, the C-terminal half of the proteasomal polyubiquitin receptor subunit p54/Rpn10 results in transcriptional down-regulation of endoproteinase I and consequently a lower level of proteolytic elimination of the polyubiquitin receptors. Another larval protease, Jonah65A-IV, which degrades only unfolded proteins and exhibits similar cross-talk with the proteasome has also been purified and characterized. It may prevent the accumulation of polyubiquitylated proteins in larvae contrary to the low polyubiquitin receptor concentration.
INTRODUCTION
The UPS (ubiquitin-proteasome system) is the major proteolytic route responsible for the controlled intracellular degradation of short-lived and misfolded proteins. The substrate selection, which is the first critical step in this highly regulated process, is ensured by the members of the ubiquitylating enzyme cascade [1] . Ubiquitin ligases, alone or in combination with ubiquitinconjugating enzymes, recognize degrons within short-lived proteins and mediate the assembly and covalent attachment of the polyubiquitin chain to the protein designated for degradation. The 26S proteasome, a large proteolytic complex which is responsible for the elimination of these proteins, is assembled in an ATP-dependent reaction from two subcomplexes [2] , the CP (catalytic particle), which executes the enzymatic cleavage of substrate proteins, and the multifunctional RP (regulatory particle). The RP selectively binds polyubiquitylated proteins, unfolds them via its anti-chaperone activity [3, 4] , reprocesses the ubiquitin residues of the substrate proteins [5, 6] , regulates the opening of the gated channel of the CP [7] and feeds the substrate into the catalytic chamber. Polyubiquitin receptors also co-operate in the processing of polyubiquitylated proteins before their proteasomal degradation by selective recognition and binding of polyubiquitylated substrates and targeting them to the RP. Two different classes of proteins have been identified that meet all of the criteria required of a polyubiquitin receptor. The proteasomal ubiquitin receptors Rpn10/S5a/p54 [8] [9] [10] [11] and Rpn13/ADRM1/p42E [12] [13] [14] [15] (yeast/human/Drosophila orthologues) are genuine subunits of the RP, whereas the extraproteasomal polyubiquitin receptors are monomeric proteins which carry two essential domains involved in their receptor function: the UBA (ubiquitin-associated domain) ensures the selective recognition and binding of the polyubiquitin chain [16] , whereas the UBL (ubiquitin-like domain) interacts with the 26S proteasome [17, 18] . Rad23, Dsk2 and Ddi1 are well-characterized members of the UBA-UBL-type polyubiquitin receptors [19] .
We have reported previously that the proteasomal and extraproteasomal polyubiquitin receptors are under strict developmental regulation in Drosophila melanogaster [20] . The concentration of p54/Rpn10 suddenly falls relative to that of other RP subunits at the beginning of larval development, remains low throughout the larval stages, starts to increase again in the wandering third instar larvae and remains high in the pupae, adults and embryos. A similar developmentally regulated fluctuation was observed in the concentrations of the two main extraproteasomal polyubiquitin receptors (Dsk2 and Rad23) functioning in Drosophila. Depletion of the polyubiquitin receptors is not accompanied by an increase in the concentration of polyubiquitylated proteins, suggesting that a hitherto unidentified proteolytic system may partially substitute for or complement the function of the UPS in larvae.
Semi-quantitative RT (reverse transcription)-PCR analysis revealed that the elimination of subunit p54 in instar stages is not a consequence of the selective transcriptional down-regulation of Pros54, which encodes the p54 protein, but is rather due to the developmentally regulated emergence of a proteolytic activity which can selectively degrade the 26S proteasome-assembled p54, leaving all the other RP subunits intact [20] . Moreover, the same proteolytic activity is responsible for the elimination of a significant proportion of Dsk2 and Rad23. In the present paper, we describe the purification, identification and characterization of this particular protease and demonstrate that the enzyme is essential in Drosophila. We also present details on the developmental-and tissue-specific regulation of the gene encoding this protease and an interesting transcriptional cross-talk between the proteasomal and this larval non-proteasomal proteolytic system in a transgenic Drosophila line that expresses the dominant-negative CTH (C-terminal half) of subunit p54/Rpn10. Furthermore, we have identified and characterized another protease in Drosophila larvae, which exhibits similar cross-talk with the proteasomal system; its unusual enzymatic properties may suggest its involvement in the elimination of misfolded proteins during instar development.
EXPERIMENTAL

DNA, RNA and protein analysis
Protocols for SDS/PAGE, immunoblotting, preparation of synchronized Drosophila samples, preparation of total RNA, cDNA synthesis and semi-quantitative RT-PCR were described previously [20, 21] . The CDS (coding sequence) of endo-I (endoproteinase I) and Jonah65A-IV were amplified from firststrand cDNA library with GoTaq TM (Promega) DNA polymerase (25 cycles of 95
• C for 30 s, 60
• C for 30 s and 72
• C for 60 s) using template-specific primers (endo-I_Fw, 5 -CCGAATTCCA-TGCTGAAGTTCGTGATC-3 ; endo-I_Rev, 5 -GCCGTCGAC-CTTAGGCATTGCTAATAA-3 ; Jonah65A-IV_Fw, 5 -GTGGA-TCCAAGATGAAGTTCCTGATCAT-3 ; Jonah65A-IV_Rev, 5 -GTATCGATTAGATGCCAGTGTTAGTCTT-3 ). The amplified CDSs were cloned into pBluescript and verified by DNA sequencing. PCRs generate a 781-bp-long fragment for endo-I, and an 834-bp-long fragment for Jonah65A-IV.
cDNA encoding the ribosomal protein L17A (rpL17A, CG3661) in the different reverse-transcribed samples was used as an internal control (indicated in the Figures). PCR was performed with different amounts of cDNA samples using rpL17A-specific primers (rpL17A_Fw, 5 -GTGATGAACTGTGCCGACAA-3 ; rpL17A_Rev, 5 -CCTTCATTTCGCCCTTGTTG-3 ) and GoTaq DNA polymerase for 22 cycles of amplification (95
• C for 60 s). This PCR generates a 268-bplong fragment from rpL17A cDNA (if genomic DNA contamination occurs, an 854-bp-long fragment is generated). PCR products were run on an agarose gel and DNA quantities giving the same band density among the different samples were used to amplify the endo-I and Jonah65A-IV cDNAs with the primers described above. To stay in the linear range of amplification, 22 cycles of the PCRs were performed; products were run on an agarose gel, stained with ethidium bromide and photographed.
Protein and nucleotide sequences were aligned using the Clustal Omega program [22, 23] operated by EMBL-EBI (http://www.ebi. ac.uk/Tools/msa/clustalo/).
Genomic DNA was prepared from adult fruitflies according to the Berkeley Drosophila Genome Project (http://www.fruitfly. org/about/methods/inverse.pcr.html).
To create a His 6 -tagged Jonah65A-IV protein, the Jonah65A-IV CDS was cloned into the BamHI/XhoI sites of a pET28a expression vector in-frame with the N-terminal His 6 tag. Construction of CBD (chitin-binding domain)-p54-CTH and FLAG-p54 was described previously [18, 20] . To make FLAGp54-CTH, the 5 half of p54 (1-614 bp) was removed from the 
TRANSGENIC FRUITFLIES
To make the double-stranded endo-I RNAi -encoding DNA construct, PCR was performed with GoTaq DNA polymerase (25 cycles of 95
• C for 60 s) using the primer pair 5 -GCTCTAGAACCTTCAGCTCCACCATCAAGGCC-3 (RNAi_Fw) and 5 -CGTCTAGACAGGCATCCTTGCCGCTG-GCAGCA-3 (RNAi_Rev) to amplify the 239-bp-long unique sequence corresponding to 379-617 bp of the endo-I CDS. The PCR fragment was digested with XbaI (sites underlined) and directly cloned first to the AvrII and then to the XbaI sites of pWIZ vector, in opposite orientations on both sides of the white intron (3 -5 -intron-5 -3 configuration) [24] . The endo-I-specific RNAi construct was designated pP{UAST-endo-I dsRNA } and verified by DNA sequencing before injecting into w 1118 embryo. To create the endo-I(1-138)-EGFP reporter construct, the genomic region between CG30028 and CG30031 genes (chr2R, 7237505-7238469; Supplementary Figure S1 at http://www. biochemj.org/bj/454/bj4540571add.htm) was PCR-amplified from genomic DNA with GoTaq DNA polymerase (25 cycles of 95
• C for 60 s) using the primer pair 5 -GACAAATAGATTTCGCGAATAAGA-3 (P_fw) and 5 -GATCTGCCAGGGGAAGCTGCTGAT-3 (P_rev). The 965-bp-long PCR product, which contains the 'intergene' (710 bp of intergenic region + 117 bp homologous segment) and the first 138 bp from the coding sequence of the CG30031 gene (Supplementary Figure S1) was TA-cloned into the pTZ57R/T vector (Fermentas) and verified by DNA sequencing. The 'intergene-endo-I(1-138)' cassette was cut out from the plasmid with EcoRI/BamHI and cloned into the pEGFP-N2 vector (Clontech) in-frame with the C-terminal EGFP tag. The 'intergene-endo-I(1-138)-EGFP' cassette was cut out from the plasmid with BglII/NotI and ligated into the BamHI/NotI sites of the promoterless pCaSpeR 4 P-element vector. The final construct was injected into w 1118 embryos. The endo-I(1-138)-EGFP mRNA in the transgenic stock was amplified from a first-strand cDNA library with P1_fw (5 -CCGAATTCCATGCTGAAGTTCGT-GATC-3 ) and P1_rev (5 -GATGAACTTCAGGGTCAGCTTG-3 ) primers (Supplementary Figure S1) .
Transformed fruitflies were selected according to standard procedures [25] . Fruitfly stocks were cultured at 25
• C on standard Drosophila food. All genetic and morphological markers used were described previously [26, 27] . Genotypes of Drosophila stocks used in the present study are given in Table 1 . Transgenic C18 and da-Gal4/C18 stocks were described previously [20] .
Protein expression, affinity purification and antibody production
The His 6 -Jonah65A-IV recombinant protein was expressed in Escherichia coli BL21(DE3) cells. Bacterial lysate was prepared by sonication in PBST (PBS + 0.1 % Triton X-100). His 6 -Jonah65A-IV formed an inclusion body, which was recovered by centrifugation, resuspended and washed three times in PBST, dissolved and boiled in SDS sample buffer and fractionated by SDS/PAGE (12 % gel). The gel was rinsed in 2 M KCl and the opaque band corresponding to His 6 -Jonah65A-IV was excised, squashed and extracted overnight in TE (10 mM Tris, pH 8.0, and 1 mM EDTA). After overnight dialysis in PBS, approximately 1 mg of protein (200 μg/boost) was used for rabbit immunization. FLAG-p54-CTH recombinant protein was expressed in E. coli BL21(DE3) cells. Proteins were affinity-purified on anti-FLAG M2-agarose beads (Sigma-Aldrich) as suggested by the manufacturer. CBD-p54-CTH affinity purification was as described previously [20] . Intrinsically unstructured proteins were expressed in E. coli BL21(DE3) cells as described previously [28] .
Endo-I protease assay
Total protein extract (10 μg) prepared from wild-type Drosophila embryos [20] was incubated at 25
• C for 1 h (unless otherwise stated) with protein extracts prepared from different larval stages extracted in buffer A (20 mM Tris/HCl, pH 7.6, 100 mM NaCl, 5 mM MgCl 2 , 1 mM DTT and 5% glycerol) or endo-Istable CHO (Chinese-hamster ovary)-K1 cells, or with fractions generated during chromatography (see below). Reactions were stopped by boiling the samples in SDS sample buffer for 5 min. Samples were fractionated by SDS/PAGE (8 % gel), blotted on to a PVDF membrane and reacted with a mixture of monoclonal antibodies recognizing different subunits of the 26S proteasome: p54/Rpn10, p48A/Rpt3, p42A/Rpn7, p39A/Rpn9 and CPα7/Prosα7 [20] .
Purification of endo-I protease
Consecutive purification steps (without freezing the active samples) were performed at 4
• C under sterile conditions. Crude total protein extract was prepared from 80 g of unsynchronized wild-type L2-L3 instar larvae in 100 ml of extraction buffer (35 mM potassium phosphate, pH 6.7, 5 mM MgCl 2 , 1 mM DTT and 5 % glycerol) with an ULTRA-TURRAX ® homogenizer. The cellular debris was removed by centrifugation at 14 000 g for 15 min at 4
• C, and nucleic acids were precipitated from the supernatant with 0.4 % streptomycin sulfate (Sigma-Aldrich) followed by centrifugation at 14 000 g for 15 min at 4
• C. Floating lipopolysaccharides were removed by filtering the protein extract through fibreglass, followed by ultracentrifugation at 100 000 g for 60 min at 2
• C. The supernatant was loaded (1 ml/min) into the hydroxyapatite chromatographic column (100 ml bed volume) which was previously equilibrated by two bed volumes of extraction buffer. The enzyme activity appeared in the flowthrough fractions. Active fractions were pooled, dialysed against buffer A and loaded into a DEAE-Fractogel ® (Merck) anion-exchange column (20 ml bed volume) equilibrated with buffer A. The enzyme activity appeared again in the flowthrough. Active fractions were pooled and loaded into a sulfo-Fractogel ® (Merck) cation-exchange column (20 ml bed volume) equilibrated with buffer A. The endo-I protease activity appeared again in the flowthrough. Active fractions were pooled, and solid ammonium sulfate was slowly added to a final concentration of 1.8 M, and samples were loaded into a 1 ml (bed volume) propyl-Fractogel ® (Merck) column equilibrated with buffer A supplemented with 1.8 M ammonium sulfate. The endo-I protease activity was eluted from the column with a 100 ml downward ammonium sulfate gradient (1.8-0 M ammonium sulfate in buffer A). Active fractions were pooled and size-fractionated on a HiLoad 16/60 Superdex 75 column (GE Healthcare) equilibrated with buffer A at a flow rate of 0.3 ml/min. Active fractions ( Figure 1) were pooled, dialysed against buffer A/50 % glycerol and stored at − 20
• C.
Jonah65A-IV protease assay
The crude protein extract of E. coli BL21 (DE3) strain expressing the recombinant FLAG-p54-CTH was used as substrate of Jonah65A-IV. Total protein (10 μg) was incubated with different Jonah65A-IV-conatining samples for 1 h (unless stated otherwise) at 25
• C in buffer A supplemented with 2 % (w/v) SDS and 2 % (w/v) 2-mercaptoethanol. The reaction was stopped by boiling the samples in SDS sample buffer for 5 min. The samples were fractionated by SDS/PAGE (9 %), blotted on to a PVDF membrane and reacted with a monoclonal antibody specific for p54.
Purification of Jonah65A-IV protease
The purification procedure is exactly the same as described above for endo-I protease, with the exception that Jonah65A-IV protease is less hydrophobic and its molecular mass is higher compared with endo-I, thus it is eluted earlier from the hydrophobic interaction column and the Superdex 75 size-exclusion column respectively.
Expression of recombinant endo-I and Jonah65A-IV proteases in CHO cells
The CDSs of endo-I and Jonah65A-IV genes were cloned into the pTRE2hyg Tet-On vector (Clontech) and transfected into CHO-K1 Tet-On cells (Clontech) using Transfast transfection reagent (Promega) according to the manufacturer's recommendations. Stably transfected cell lines were selected on hygromicin, and the expression of the recombinant genes was induced by doxycycline (3 μg/ml, for 48 h). Cell lines with the highest expression level were selected and lysed in buffer A ( + 0.1 % Nonidet P40) on ice. The catalytic activity of the recombinant endo-I was tested by demonstrating the selective degradation of subunit p54 from Drosophila 26S proteasome. The catalytic activity of the recombinant Jonah65A-IV was tested under native condition or in the presence of SDS and 2-mercaptoethanol using FLAG-p54-CTH protein as substrate.
Immunostaining and fluorescence microscopy
Tissue specimens were prepared as follows: the larvae were opened with two forceps on silicon-based dissection pad, the epidermis was flattened and immobilized with insect needles (0.15 mm diameter minutiens; Austerlitz Insect Pins). Opened larvae were fixed with 2 % (w/v) paraformaldehyde for 15 min in PBS, washed three times for 5 min in PBS and then blocked with 0.1 % BSA in PBS supplemented with 0.01 % Triton X-100 for 20 min. The antibodies were diluted using the same solution. The primary anti-Jonah65A-IV antibody (1:2000 dilution) was used to visualize the protein distribution in larval organs, with overnight incubation at 4
• C. Following the washing in PBS (three times for 20 min), a secondary Alexa Fluor ® 488-conjugated anti-rabbit antibody was used (Molecular Probes/Invitrogen) at a dilution of 1:800. Nuclei were stained with DAPI (Sigma), applied together with the secondary antibody.
Visualization of GFP
Samples were dissected, fixed and washed as described above. Nuclei were stained with DAPI (Sigma) diluted in PBS by incubating the samples for 15 min. After staining, both sample types were washed three times for 20 min in PBS, and mounted in Fluoromount G (Southern Biotech).
Microscopy
Olympus FV1000 and Leica SP5 laser-scanning confocal microscopes were used with the following objectives: Olympus UPLSAPO 10× NA (numerical aperture) 0.40 and UPLSAPO 60× O NA 1.35, Leica HC PL FLUOTAR 10.0× NA 0.30 and HCX PL APO 63.0× NA 1.40 oil. Images were exported and fluorescence intensity measurements were done using FIJI (Image J, NIH) as follows: Z-stack images were recorded from the gut [from seven C18 (control) and five p54-CTH-overexpressing (da-Gal4/C18) individuals respectively], using the 10× objective of the Leica confocal microscope. The images from C18 and da-Gal4/C18 were recorded by using the same settings. A Zprojection was generated, four measurements were made using the line tool, along each lobe of gastric caeca. The average of these four mean intensity values was used to generate the individual values, which were subjected to Student's t test.
Protein identification by MS
In-gel digestion of the protein bands was performed according to the protocol at http://msf.ucsf.edu/ingel.html. The tryptic digests were subjected to MALDI-TOF as well as LC-MS/MS analyses. MALDI-TOF analysis was performed on a Bruker Reflex III mass spectrometer in reflectron mode in the 1-4 kDa and 3-6 kDa mass range using a 2,5-dihydroxybenzoic acid matrix. LC-MS/MS analysis was performed either on an Agilent XCT Plus or a Thermo Scientific LCQ Fleet ion-trap mass spectrometer in information-dependent acquisition mode. The peptides were separated on a 75 μm×150 mm C 18 column with a flow rate of 350 nl/min at a gradient of 5-45 % solvent B in 25 min; solvent A, 0.1 % formic acid/water; solvent B, 0.1 % formic acid/acetonitrile; trapping, 15 μl/min for 3 min in solvent A. MS and MS/MS data were searched against Drosophila entries in the 2011.06.10 NCBI non-redundant protein database (44 402/14 324 397 sequences) using an in-house Mascot server (version 2.2.04). For MALDI-TOF data, monoisotopic masses within 200 p.p.m. mass accuracy were considered. For the iontrap data, monoisotopic masses with precursor mass tolerance of + − 1 Da and fragment mass tolerance of + − 0.8 Da were submitted. Two missed cleavages were permitted. Carbamidomethylation of cysteine residues was set as fixed modification, and acetylation of protein N-termini, methionine oxidation and pyroglutamic acid formation from peptide N-terminal glutamine residues as variable modifications. Peptide matches with a score >38 (P < 0.05) were accepted.
RESULTS
Purification, identification and characterization of the serine protease responsible for the selective depletion of polyubiquitin receptors
The selective degradation of subunit p54, present in an intact 26S proteasome particle, served as an enzymatic assay to follow the purification of the protease. The crude total protein extract prepared from unsynchronized second (L2) and third (L3) instar larvae was fractionated on a series of chromatographic columns (detailed in the Experimental section), fractionating the proteins by their different physicochemical properties. As shown in Figure 1 The purified enzyme displays strict cleavage specificity in the selective elimination of subunit p54 from the 26S proteasome particle ( Figure 1B ) as well as the extraproteasomal polyubiquitin receptors Dsk2 and Rad23 [20] (results not shown). The specificity of the purified protease raised the question of whether the annotation by FlyBase (based on amino acid sequence homology) is correct. To test the cleavage specificity of the enzyme, the affinity-purified CBD-tagged recombinant CTH of p54 (this half of the molecule is the in vivo target of the specific protease [20] ) was exhaustively digested with the purified larval serine protease and also with a commercially available porcine trypsin (serving as a control) respectively. The peptides generated by the two proteases were analysed by MS and compared with the known amino acid sequence of CBDp54-CTH (Supplementary Figure S4 at generated by our purified enzyme adjacent to basic amino acids characteristic of trypsin, the majority of the cleavages occurred at amino acids where trypsin never cuts substrate proteins. Although our data are not sufficient to establish the consensus cleavage specificity of the purified enzyme, we unequivocally state that the annotation of this enzyme as a Drosophila trypsin may not be correct. We therefore denote this enzyme as endoproteinase I (endo-I). Drosophila endo-I is encoded by a multigene family represented by three identical and ten highly homologous gene copies (Supplementary Figure S3) , which are clustered in the 2R chromosome arm between cytological regions 47F3 and 47F5. Specific PCR primers were designed for the amplification of cDNA encoding the identical paralogues of endo-I protein (CG30028, CG30031 and CG12351). The RT-PCRbased cloning was performed on first-strand cDNA prepared from second instar larvae. We have shown previously that the protease activity which selectively degrades the polyubiquitin receptors displays a characteristic developmental profile [20] : the activity emerges in the early L2 instar larval stage, peaks in late L2 and early L3 larvae, and declines slowly during the L3 instars, whereas in 120-h-old wandering L3 larvae, it is almost undetectable. In embryos, pupae and adults, our test system failed to detect this specific proteolytic activity. To test whether this developmental fluctuation is regulated at a gene expression level, total RNA was prepared from different developmental stages of synchronously developing wild-type animals, and the concentration of endo-I mRNA was estimated by semi-quantitative RT-PCR. As shown in Figure 2(A) , the level of endo-I mRNA was low in embryos and L1 larvae, increased sharply during the L2 stage and, like the specific proteolytic activity [20] , peaked in 72-84-hold L2/L3 larvae. Then it declined during the L3 stage, and was almost undetectable in the pupae and adults. These results are in good agreement with the developmental time-course RNA-Seq [30] high-throughput dataset presented in FlyBase.
As endo-I is encoded by a multigene family, the contributions of the individual endo-I gene copies to the overall expression profile cannot be estimated; nevertheless, proteins translated from different endo-I mRNA paralogues should exhibit identical enzymatic properties. Further investigation is required to analyse the enzymatic properties and the biological function(s) of proteins encoded by the partially homologous gene copies of the endo-I locus.
To determine the tissue-specific localization of the enzyme, we first attempted to raise antibody against the purified enzyme. As our repeated attempts failed, we generated a transgenic Drosophila line in which a chimaeric protein composed of the first 46 amino acids (1-138 bp) of endo-I and EGFP [endo-I(1-138)-EGFP] was expressed under the control of the authentic endo-I promoter. In the 47F4 cytological region, two identical paralogues of endo-I-encoding genes (CG30028 and CG30031) are localized in opposite orientations (Supplementary Figure  S1) . It appeared reasonable to suppose that the 944 bp DNA segment separating the gene copies contains all of the regulatory sequences required for the spatiotemporal expression of these genes. As shown in Supplementary Figure S1 , upstream of the transcriptional start site of the gene copies, there is a 117-bp-long perfectly homologous DNA sequence (probably the minimal promoter) separated by a 710-bp intergenic region. This intergenic region, together with the presumed minimal promoter and the first 138 bp coding sequences of the CG30031 (endo-I) gene copy, was PCR-amplified from genomic DNA and ligated in-frame to EGFP. This cassette was subcloned into the promoterless pCaSpeR-4 P-element-based transformation vector, which was then used to establish transgenic Drosophila lines. The expression of the chimaeric EGFP-fusion protein was examined by fluorescence microscopy. As shown in Supplementary Figure  S5 Figure  S5C , arrow) in the cytosol, for which distribution is reminiscent of that of the proteins of the Golgi apparatus. In other larval tissues, fluorescence was not detected. The presence of the EGFP sequence allowed simultaneous measurement of the mRNAs encoding the endo-I(1-138)-EGFP chimaeric protein and the authentic endogenous endo-I. Semi-quantitative RT-PCR analysis revealed that the developmental stage-specific regulation of this transgene was identical with that of the endogenous endo-I genes ( Figure 2B ), confirming our assumption that the cloned genomic DNA segment upstream of the transcription start site of the endo-I-coding sequences contains all of the necessary regulatory elements required for the tissue-and developmentalstage-specific regulation of transcription.
Owing to the fact that endo-I is encoded by at least three identical (and several similar) paralogues in Drosophila, classical genetic techniques were not suitable for the analysis of endo-I's function in vivo. On the other hand, by exploiting the high sequence homology of the members of the endo-I locus, we could perform RNAi-induced gene silencing and simultaneously deplete the mRNAs transcribed from the different gene copies, allowing the analysis of the phenotypic effect of endo-I downregulation. We have chosen a unique segment within endo-I (379-617 bp), which is identical in the genomic copies of four paralogues of endo-I and exhibits high sequence similarity to two other members of this multigene family, but does not carry the highly conserved sequence motifs present in all serine proteases [29] . This sequence, which does not show any off-target homology with transcripts of the Drosophila database [31] , was cloned into the Gal4-inducible [32] UAS (upstream activation sequence)-based pWIZ RNAi vector [24] . Transgenic Drosophila lines were selected and the phenotypic effect of the da-Gal4 driverinduced gene silencing was analysed in parallel with the changes in endo-I enzymatic activity. The two responder transgenic lines (endo-I RNAi : 25/1 and 40/1), which were characterized in detail, were viable and fertile without any detectable phenotypic changes before crossing with the da-Gal4 constitutive driver. Gene silencing induced by crossing the responder lines with the da-Gal4 driver resulted in 100 % early pupal lethality in the 25/1-da-Gal4 line (strong RNAi; results not shown). The lethal phenotype of the 40/1-da-Gal4 line (mild RNAi; results not shown) was less severe: approximately 50 % of the animals died in brown pupal stages, whereas the other half survived until the pharate adult stage, but none of them emerged to adult flies. The change in endo-I enzymatic activity after RNAi-induced gene silencing was analysed in the synchronously developing 25/1-da-Gal4 and 40/1-da-Gal4 transgenic lines. The non-induced 25/1 line served as a control. As shown in Figure 3 , selective degradation of subunit p54 of the 26S proteasome is severely inhibited in a total larval extract prepared from 84-h-old 25/1-da-Gal4 larvae compared with the activity of the 84-h-old non-induced larval extract [25/1 (CTRL)]. In agreement with the differences in the lethality properties of the 25/1-da-Gal4 and 40/1-da-Gal4 transgenic lines, RNAi-induced gene silencing resulted in only weaker inhibition of the endo-I enzyme activity in the 40/1-da-Gal4 line.
Cross-talk between endo-I and the proteasome system
We demonstrated previously that in transgenic Drosophila lines, which overexpress the CTH of subunit p54/Rpn10 (da-Gal4/C18 [20] ), the developmental-stage-specific regulation of the proteolytic activity which selectively degrades the polyubiquitin receptors, i.e. the Drosophila endo-I as identified in the present study, is severely disturbed [20] . The decline of this proteolytic activity, which occurs in late L3 stage in wild-type Drosophila, is initiated much earlier in the da-Gal4/C18 transgenic line. The interplay between the proteasomal and this larva-stage-specific non-proteasomal proteolytic system may be a consequence of a developmentally regulated change in the transcriptional regulation of endo-I expression. This assumption was tested by measuring the mRNA concentration of endo-I in synchronously developing C18 (non-induced) and da-Gal4/C18 (induced) transgenic lines by semi-quantitative RT-PCR. As shown in Figure 4 , the presence of p54-CTH strongly suppresses the expression of endo-I in a developmentally regulated fashion: down-regulation of endo-I starts much earlier in da-Gal4/C18 transgenic larvae than in the control larvae. In addition, the developmental expression profile of the p54-CTH-induced down-regulation of the transgene-encoded endo-I(1-138)-EGFP chimaeric protein was exactly the same as that of endo-I (Figure 4 ). Moreover, a significant difference between the fluorescence intensities measured in cells of the gastric caeca in C18/endo-I(1-138)-EGFP (serving as control) compared with that of the da-Gal4/C18/endo-I(1-138)-EGFP L2 larvae (Supplementary Figure S6 at http://www.biochemj.org/bj/454/bj4540571add.htm) confirmed further the negative regulatory effect of p54-CTH on the endo-I expression and negative-feedback-regulated cross-talk between these two systems. These observations support further the assumption that the genomic DNA sequence inserted upstream of the EGFP gene contains all of the relevant transcriptional regulatory elements of endo-I, and that transcriptional downregulation is the mechanism via which disturbance of the UPS influences the endo-I gene.
Purification, identification and characterization of a larval protease specific for unfolded proteins
The role of the UPS in the elimination of misfolded proteins generated inside the ER (endoplasmic reticulum) is well established {the ERAD (endoplasmic-reticulum-associated degradation) system [33] }. This is in sharp contrast with our limited knowledge on the presumed function of the UPS in the elimination of misfolded or irreversibly denatured proteins generated in other cellular compartments. The highly anaerobic environment during larval development may generate high amounts of misfolded proteins, making the larvae an ideal test object in the search for proteases which may be involved, alone or in co-operation with the proteasomal system, in the elimination of damaged proteins. The interplay between the proteasomal system and endo-I suggests that such co-operation is feasible in the controlled intracellular protein degradation process. Obviously, a key element of that kind of co-operation, a protease specific for the elimination of misfolded or denatured proteins, is still lacking. We therefore made a search for larval proteases with a marked preference for unfolded proteins. A protein extract prepared from L2 instar larvae was incubated under native or denaturing conditions, and the fate of the proteins was followed by SDS/PAGE. Protein denaturation was achieved by increasing the concentrations of SDS and/or the reducing agent 2-mercaptoethanol. Surprisingly, we detected proteolytic activity in larvae which is robust only under strongly denaturing conditions. As shown in Figure 5 (A), a very modest degradation of larval proteins occurred when the extract was incubated under native conditions over a 3 h incubation period, whereas in the presence of 2 % SDS and 2 % 2-mercaptoethanol, all of the proteins present in the total larval protein extract were degraded to oligopeptides within 15-30 min. Using denatured recombinant p54-CTH as model substrate, we succeeded in purifying this protease. It turned out that the physicochemical properties of the enzyme are very similar to those of endo-I. It copurifies with endo-I during the first three chromatographic steps, but, as it is less hydrophobic and larger, it can be separated from endo-I on both the hydrophobic interaction and the size-exclusion columns. The result of the final purification step is illustrated in Figure 5 (B). Superdex 75 fractions were run on SDS/PAGE and proteins were visualized by silver staining. A strong band which appeared in fractions 26-30 was identified by MS as regucalcin (CG1803). Fractions 30-54 displayed strong proteolytic activity. In fractions 38-48, besides traces of the regucalcin, three closely spaced protein bands appeared after SDS/PAGE (14 % gel) ( Figure 5B ). MS revealed that all three individually excised and analysed bands ( Figure 5B , bands a-c, and Supplementary Figure S7 at http://www.biochemj.org/bj/454/bj4540571add.htm) corresponded to Jonah65A-IV serine protease (CG6467). The multiplicity of the protein bands was probably due to different processing or post-synthetic modifications of the protein (see below); however, we could not prove this by MS analysis. Fractions 41-48 were pooled and used for further enzymatic studies. The Jonah proteases had been identified previously at genomic DNA and transcript levels, but the proteases encoded by these genes, and their properties, had not been characterized to date [34] [35] [36] . These proteases, like endo-I, are encoded by a multigene family. The sequence of the individual gene copies, however, is much less conserved compared with the members of the endo-I gene family.
In the absence of denaturing agents, the purified endogenous Jonah65A-IV enzyme is completely inactive when recombinant p54-CTH is used as substrate. In the presence of 2 % SDS and 2 % 2-mercaptoethanol, a fairly resistant fragment of a welldefined length emerged as partial digestion product ( Figure 5B , intermediate product) during the initial phase of digestion when full-length p54 (results not shown) or its CTH were used as substrates. This partial digestion product was preserved over a fairly broad enzyme concentration range, and was degraded to oligopeptides following prolonged incubation. The formation of a transiently protected fragment was observed for several other model substrate proteins (results not shown). The dependence of the proteolytic activity on the presence of SDS and 2-mercaptoethanol might suggest that denaturation of the substrate proteins, complete unfolding of Jonah65A-IV or the dissociation of a specific inhibitor is a prerequisite for this peculiar proteolytic process. It appeared more reasonable to suppose that complete unfolding of the substrate proteins or the enzyme, but not the dissociation of an inhibitor, is required for the proteolytic activity. To test this assumption, we chose well-characterized intrinsically unstructured proteins [28] as model 'unfolded' substrates and followed their digestion by purified Jonah65A-IV under native conditions. As shown in Figure 6 , the recombinant intrinsically unstructured proteins [ERD-10 (early responsive to dehydration 10), NACP (non-amyloid-β component of Alzheimer's disease precursor) and FRET-1-3-14 (unstructured region of the giant muscular protein titin)] present in total bacterial protein extracts were rapidly digested under native conditions, whereas the bacterial proteins or a globular recombinant protein (Gly-H) remained intact. These data support our idea that, under native conditions, the enzyme selectively recognizes and degrades unfolded/unstructured proteins.
On the basis of the genomic DNA sequence data, PCR primers were designed for the amplification of the cDNA encoding Jonah65A-IV, and the developmental regulation of Jonah65A-IV gene expression was analysed in synchronously developing wild-type Drosophila samples by semi-quantitative RT-PCR. The expression of the Jonah65A-IV gene is very low in early embryos, modest in late embryos and L1 larvae, increases sharply during larval stages L2/L3 and peaks in 72-84-hold L2/L3 larvae, then a decline starts from the white pupal stage. In brown pupae and pharate adults, the level is almost non-detectable, and the transcript concentration becomes high again in adults ( Figure 7A ). These results are consistent with the developmental time-course RNA-Seq [30] Crude bacterial protein extracts prepared from untransformed E. coli BL21(DE-3) cells (CTRL) and from bacteria expressing intrinsically unstructured recombinant ERD-10, FRET-1-3-14 and NACP proteins or the recombinant globular Gly-H proteins were incubated with the purified Jonah65A-IV enzyme under native conditions. Degradation of the proteins was followed by Coomassie Brilliant Blue staining after SDS/PAGE (10 % gel). Asterisks indicate recombinant protein.
The developmental fate of the Jonah65A-IV protein was analysed further by immunoblot assay in protein extracts prepared from the same synchronously developing wild-type Drosophila samples as were analysed by RT-PCR. The polyclonal antibody used in the immunoblotting experiment was raised against the affinity-purified recombinant His 6 -tagged Jonah65A-IV. As revealed in Figure 7 (B), only trace amounts of immunoreactive protein were detected in 0-24-h-old embryos. This is in sharp contrast with the high concentration of Jonah65A-IV protein present in 36-h-old L1 larvae. The concentration of Jonah65A-IV increases further during the L2 instar larval stage, reaches its peak in the early L3 instar larvae and starts to decline thereafter. During larval development, there are characteristic changes in the distribution of the different isoforms (or modified/processed forms) of the protein. From the late L2 phase until the pupariation, a low-molecular-mass immunoreactive band appears, with indirect evidence suggesting its relation to the Jonah65A-IV protease (see below). In the pupae, only a small amount of Jonah65A-IV is present, whereas in the adult fruitflies, besides a faint amount of Jonah65A-IV protein a smaller, but strongly immunoreactive, band appears. We purified this polypeptide until homogeneity, but MS analysis revealed that it, i.e. sarcoplasmic calcium-binding protein 1, is not related to Jonah65A-IV.
The developmental profile of the Jonah65A-IV protease activity was determined in total protein extracts prepared from synchronously developing wild-type Drosophila samples. Recombinant p54-CTH was incubated in a reaction mixture containing 2 % SDS and 2 % 2-mercaptoethanol with equal quantities of total proteins prepared from the synchronously developing Drosophila samples, and the degradation of the CTH was followed by immunoblot assay with a monoclonal antibody specific for p54. As may be seen in Figure 7 (C), a close correlation was found between the activity profile and the quantity of Jonah65A-IV protein determined with the enzyme-specific polyclonal antibody ( Figure 7B ). The gene expression profile data obtained with RT-PCR, the Jonah65A-IV protein distribution detected by immunoblotting and the Jonah65A-IV enzyme activity profile are congruent, with the only exception that, in adult fruitflies, the mRNA concentration is high compared with the level and activity of the enzyme. This observation may suggest an miRNA-induced translational repression, although bioinformatic analysis with miRanalyzer (http://web.bioinformatics.cicbiogune. es/microRNA/miRanalyser.php) software [37] did not recognize a target site in the Jonah65A-IV mRNA for any miRNA known at present. Further study is needed for the clarification of this issue.
The tissue-specific distribution of Jonah65A-IV was analysed by immunostaining in dissected L2 and L3 instar larvae. As indicated in Supplementary Figure S8 (at http://www.biochemj. org/bj/454/bj4540571add.htm), the gastric caeca is the only larval tissue in which strong Jonah65A-IV staining was found. Thus the tissue-specific distributions of the Drosophila endo-I and Jonah65A-IV proteases are exactly the same. It is important to note that these proteases were not detected inside the lumen of the digestive tract, although the staining inside the cells of the gastric caeca was very intensive for both proteases ( Supplementary  Figures S5 and S8) . 
Cross-talk between Jonah65A-IV and the proteasome system
The similarities in the tissue-and developmental-stage-specific regulation of the endo-I and Jonah65A-IV expression raised the question whether there is any cross-talk between the proteasomal system and the Jonah65A-IV protease, similar to that observed for endo-I. To answer this question, we tested the developmentalstage-specific expression of Jonah65A-IV in synchronously developing C18 and da-Gal4/C18 [20] transgenic Drosophila larvae by semi-quantitative RT-PCR. Figure 8 (A) reveals that, in the absence of the transgenic CTH protein (in C18 control line), the larval expression profile of Jonah65A-IV is identical with that seen in wild-type larvae ( Figure 7A ). Overexpression of the transgenic CTH protein (in the da-Gal4/C18 line) induced a serious depletion of the Jonah65A-IV transcript. Depletion was already detectable in the early L3 instar larvae, and the most extensive down-regulation of Jonah65A-IV expression occurred in the late L3 instar larvae. Immunoblotting analysis demonstrated a similar depletion of Jonah65A-IV protein upon overexpression of the transgenic CTH protein ( Figure 8B ). In parallel with the decline in the intensity of the intact Jonah65A-IV polypeptides, there was an accumulation of a lower-molecular-mass Jonah65A-IV-immunoreactive band, which is also present, at much lower concentration, in the wildtype late L3 instar larvae. This observation strongly suggests that the lower-molecular-mass band is a degradation product of the functional Jonah65A-IV, and that this degradation is a physiological process in the elimination of the protease in the late L3 instar larvae, a process which is being boosted following the overexpression of CTH. 
Recombinant endo-I and Jonah65A-IV possess the expected specific enzymatic activities
According to FlyBase, endo-I and Jonah65A-IV are members of two multigene families. Moreover, as we learnt from the RNA-Seq [30] dataset, the developmental expression profile of endo-I or Jonah65A-IV is very similar to that of other genes (including members of the endo-I as well as the Jonah65A-IV locus) which were also annotated as proteolytic enzymes. Owing to this complexity, it is very difficult to unambiguously identify the gene(s) responsible for the enzymatic activities and biological properties described above. Therefore we needed to ascertain whether the enzymes identified by MS analysis exhibit the expected enzymatic activities. To test this, we aimed to express the cloned genes of these enzymes in a heterologous system and analyse the enzymatic properties of recombinant endo-I and Jonah65A-IV in vitro. Proteins expressed in E. coli formed inclusion bodies, thus they were enzymatically inactive. Therefore we switched to express endo-I and Jonah65A-IV in a higher eukaryotic cell using the inducible Tet-On system in CHO-K1 cells. The characteristic endo-I or Jonah65A-IV enzymatic activities (selective degradation of subunit p54 of the Drosophila 26S proteasome or SDS/2-mercaptoethanol-dependent selective cleavage of FLAG-p54-CTH protein respectively) are not detectable in the non-transfected CHO-K1 Tet-On cell line irrespective of the presence or absence of the expression-inducer doxycycline ( Figure 9 ). In contrast, the extract of the doxycyclineinduced endo-I stable cell line exhibited the characteristic endo-I enzymatic activity: subunit p54 of the Drosophila 26S proteasome was selectively degraded, leaving all of the other subunits intact ( Figure 9A) . Similarly, the extract of the doxycyline-induced Jonah65A-IV stable cell line specifically cleaved its model substrate (FLAG-p54-CTH protein) exclusively in the presence of 2 % SDS and 2 % 2-mercaptoethanol and generated the characteristic intermediate proteolytic product; however, under native conditions, this cleavage activity was completely lacking ( Figure 9B ). These results provide sufficient evidence that endo-I can selectively eliminate p54 from the intact 26S proteasome, whereas Jonah65A-IV is responsible for the degradation of denatured proteins. The investigation of the involvement of other members of these two multigene families (especially those with similar expression profile and sequence) in such biological processes remains a future challenge.
DISCUSSION
During the larval development of D. melanogaster, there is a pronounced down-regulation of the proteasomal and extraproteasomal polyubiquitin receptors [20] . Surprisingly, depletion of the polyubiquitin receptors is not accompanied by the accumulation of polyubiquitylated proteins, which suggests that hitherto unknown proteolytic activities may be involved in the elimination of short-lived or misfolded proteins in larval tissues. Depletion of the polyubiquitin receptors during the larval stages is due to a developmentally regulated emergence of proteolytic activity which can selectively degrade the polyubiquitin receptors. We assume that a delicate balance of the proteasome system and this putative proteolytic activity is a prerequisite for appropriate cellular homoeostasis. This assumption is supported by the observation that overexpression of the CTH of subunit p54, the polyubiquitin receptor subunit of the 26S proteasome, disturbs the developmental fate of the polyubiquitin receptors, influences the developmentally regulated emergence of the polyubiquitin receptor-specific proteolytic activity, results in a huge accumulation of polyubiquitylated proteins and causes larval lethality [20] . In the present study, we discovered two different Drosophila larval serine proteases (endo-I and Jonah65A-IV) which participate in pronounced cross-talk with the proteasome system, i.e. they respond to the transgenic overexpression of p54-CTH, and their unusual substrate specificity may explain their involvement in the elimination of misfolded proteins. We found that endo-I is responsible for the developmentalstage-specific depletion of the polyubiquitin receptor subunit of the 26S proteasome in Drosophila. Two different lines of evidence confirmed its involvement in polyubiquitin receptor homoeostasis. Our in vitro studies revealed that endo-I can selectively degrade subunit p54 present in an intact 26S proteasome particle, leaving all other proteasomal subunits intact. Selective degradation of the extraproteasomal polyubiquitin receptors by endo-I was also demonstrated [20] . Our in vivo studies also suggested a cross-talk between endo-I and the UPS: induced overexpression of the C-terminal part of p54, which has a dominant-negative effect in transgenic fruitflies [20] , resulted in a transcriptional down-regulation of endo-I, which explains the serious disturbance in the developmental regulation of the polyubiquitin receptors in these transgenic animals [20] .
The lethality of the endo-I-depleted transgenic mutants unambiguously proves that Drosophila endo-I is not simply a digestive enzyme required in high quantity during the larval stages when the feeding activity is very high, but it may either cause the damage of a vital function(s), which is manifested only in the pupae, or, in contrast with its very low concentration in the pupae, it may have an essential role in this morphogenetic stage too. Perhaps because of its very high concentration in the larvae, RNAi-induced gene silencing cannot suppress the enzyme activity to the level required to damage its vital function(s) in the larvae. In the analysis of the essential role of endo-I during Drosophila development, the potential functional substitution of the different paralogues of endo-I should also be considered.
Jonah65A-IV was the second larval serine protease characterized in the present study. The most noteworthy enzymatic property of Jonah65A-IV was its strict preference for unfolded proteins. Although unstructured polypeptides are more easily degraded by almost all proteases characterized so far, the extreme shift in the substrate preference of Jonah65A-IV is unusual. Almost all detectable proteins present in total protein extracts prepared from different developmental stages of Drosophila proved to be fully resistant to Jonah65A-IV under native conditions, but they are easily and rapidly degraded under denaturing conditions. We proved that denaturing conditions are required for the unfolding of the substrate proteins, but not the enzyme. The resistance of Jonah65A-IV to SDS and 2-mercaptoethanol-induced denaturation suggests an extended β-sheet-structure-induced structural rigidity of the enzyme [38] .
Several important properties of endo-I and Jonah65A-IV are common. Both enzymes are serine proteases encoded by multigene families, and they are expressed exclusively in the gastric caeca in a highly similar developmentally regulated choreography. During the L2 and early L3 larval stages, the expression of endo-I and Jonah65A-IV is very high in wildtype Drosophila, whereas the concentration of the polyubiquitin receptors in these developmental stages is low, due to the selective degradation by endo-I. This reciprocal relationship is reversed in the late larval stages. In contrast with the low polyubiquitin receptor concentration in the larvae, there is no detectable accumulation of polyubiquitylated proteins [20] , suggesting that Jonah65A-IV and/or endo-I (or other so far uncharacterized members of their families) may complement or support the function of the UPS. This assumption is supported by the observation that the two enzymes participate in similar cross-talk with the UPS. Overexpression of p54-CTH in transgenic fruitflies disturbs the developmental fate of the polyubiquitin receptors [20] and these larval proteases: the expression of endo-I and Jonah65A-IV is suppressed and the build-up of the polyubiquitin receptors starts earlier during the larval development. In contrast with the premature accumulation of the polyubiquitin receptors, caused by the presence of p54-CTH, there is a huge accumulation of the polyubiquitylated proteins [20] , suggesting that the processing of the UPS substrates during the larval developmental stages requires high concentrations of Jonah65A-IV and/or endo-I. It should be noted that the overexpression of the transgenic p54-CTH causes larval lethality. It is a matter of speculation whether this phenotype is a consequence of the disturbance of these larval proteases, or whether the p54-CTH protein interferes with other vital cellular processes.
Although our results suggest the involvement of Jonah65A-IV in the elimination of misfolded proteins during the larval developmental stages when the function of the UPS is muted due to the low polyubiquitin receptor concentration, these results are only circumstantial, and further investigation is required to prove the above hypothesis.
The tissue-specific-expression of endo-I and Jonah65A-IV in the gastric caeca is one of their most important common properties. The function of the gastric caeca is not clear; there is no unequivocal experimental evidence in support of the assumption that it is exclusively an exocrine gland secreting digestive enzymes into the gut. The lethality of the RNAi-induced down-regulation of endo-I during the pupal stage, when there is no digestive activity at all, suggests its widespread function. The very low endo-I and Jonah65A-IV activity in adult fruitflies, with very high digestive activity and with a preserved gastric caecal structure, lends further support to this assumption.
The enzymatic properties of recombinant endo-I and Jonah65A-IV expressed in CHO cells clearly indicate that proteins encoded by those members of the multigene families identified by MS fulfil the biological functions described above. The enzymatic properties of proteases encoded by homologous copies of endo-I genes should be identical, but the mutations accumulated in other copies of these paralogues may generate significant functional redundancies. This functional redundancy may be even more extensive in the proteases encoded by different members of the Jonah locus, being the sequence divergence in this gene family much more extensive.
The proper folding of newly synthesized polypeptides is a complicated process assisted by several chaperone proteins. This process is frequently impaired under stress conditions, generating misfolded or irreversibly denatured proteins. Accumulation of such misfolded proteins is harmful for the cell, and can be the basis of several serious human diseases. The formation of misfolded proteins is most frequent inside the ER, because of the formation of the complicated disulfide bond structures essential for the correct folding of the secretory proteins, but also because of the complicated process of multisubunit protein assembly. A well-characterized system, the ERAD [33] , in co-operation with the UPS evolved for the elimination of misfolded proteins from the ER. Outside the ER, the formation of complicated disulfide bond structures is very rare; nevertheless, the proper folding of functionally intact proteins is a complicated process, which frequently fails. Our knowledge of the mechanism ensuring the elimination of misfolded proteins generated outside the ER is very limited. In the yeast Saccharomyces cerevisiae, Nillegoda et al. [39] described that Ubr1 and Ubr2 ubiquitin ligases, in association with the Hsp70 (heat-shock protein 70) chaperone promoted the degradation of unfolded or misfolded cytosolic polypeptides. The role for Ubr2 in cytosolic quality control processes, however, was not confirmed by others [40] . Furthermore, conflicting results have been published on the role of Ydj1 in the degradation of misfolded cytosolic proteins: some authors claimed that Ydj1 promotes degradation of misfolded proteins [40] , whereas others showed that Ydj1 only protects newly synthesized protein kinases [41] . Our knowledge relating to the fate of misfolded cytosolic proteins in higher eukaryotic cells is even more limited, and the interpretation of the experimental results is controversial [42] [43] [44] [45] .
The co-operation of a hitherto uncharacterized proteolytic system(s) and the proteasome in the elimination of misfolded proteins may be an alternative mechanism. Our observations concerning the emergence of the Jonah65A-IV protease, which displays extreme specificity towards unfolded proteins and, its co-operation with the UPS may lend support to the assumption that its major function is the elimination of misfolded proteins during the larval stages.
AUTHOR CONTRIBUTION
Zoltán Lipinszki performed the majority of the molecular experiments and genetic analysis, contributed to the design and co-ordination of the project, assembled Figures and cowrote the paper. MS was performed by Eva Klement, Eva Hunyadi-Gulyas and Katalin Medzihradszky and Róbert Márkus carried out the immunostaining and fluorescence microscopy. Margit Pál and Péter Deák were involved in the construction of transgenic animals. Andor Udvardy was involved in the molecular experiments, designed and coordinated the project and wrote the paper. CLUSTAL O(1.1.0) multiple sequence alignment of serine proteases encoded by the endo-I multigene family
LGIYAVSAQSDGRIVGGADTSSYYTKYVVQL ***: * :.:
RRR--SSSSSSYAQTCGGCILDAVTIATAAHCVYNREAE-NFLVVAGDDSRGGMNGV--V : : *.* : : ::.:*: * * CG30028 FSVSSFKNHEGY-NANTMVNDIAIIKINGALTFSS --TIKAIGLASSNPANGAAASVSGW  CG12351  FSVSSFKNHEGY-NANTMVNDIAIIKINGALTFSS--TIKAIGLASSNPANGAAASVSGW  CG30031  FSVSSFKNHEGY-NANTMVNDIAIIKINGALTFSS--TIKAIGLASSNPANGAAASVSGW  CG30025  FSVSSFKNHEGY-NANTMVNDIAIIKINGALTFSS--TIKAIGLASSNPANGAAASVSGW  CG18444  AKVSSFKNHEGY-NANTMVNDIAVIRLSSSLSFSS--SIKAISLATYNPANGASAAVSGW  CG18211  AKVSSFKNHEGY-NANTMVNDIAVLHLSSSLSFSS--TIKAIGLASSNPANGAAASVSGW  CG18681  HSVRSFRNHEGY-NSRTMVNDIAIIRIESDLSFRS--SIREIRIADSNPREGATAVVSGW  CG7754  VPVAAYKVHEQF-DSRFLHYDIAVLRLSTPLTFGL--STRAINLASTSPSGGTTVTVTGW  CG12385  VAVRELAYNEDY-NSKTMEYDVGILKLDEKVKETE--NIRYIELATETPPTGTTAVVTGW  CG12350  LEVREIIIHPKY-RTLNNDYDAAILILDGDFEFND--AVQPIELAKERPDHDTPVTVTGW  CG12388  YPVANWTHHPNY-DPVTVDNDIGVLLLDTTLDLTLLG-ISSIGIRPERPAVGRLATVAGW  CG12387  TNVKEIVMHEGYYSGAAYNNDIAILFVDPPLPLNNFT-IKAIKLALEQPIEGTVSKVSGW   CG12350   CG12388   CG12387   CG12386   CG12385   CG18444   CG18681   CG18211  CG30028   CG30031   CG30025   CG12351 
CG7754
Chrom. (2R): 47F3-47F5
Genomic localization of the 13 endo-I-like serine proteases: CG30028  MLKFVILLSAVACALGGTVPEGLLPQLDGRIVGGSATTISSFPWQISLQRSGSHSCGGSI  CG12351  MLKFVILLSAVACALGGTVPEGLLPQLDGRIVGGSATTISSFPWQISLQRSGSHSCGGSI  CG30031  MLKFVILLSAVACALGGTVPEGLLPQLDGRIVGGSATTISSFPWQISLQRSGSHSCGGSI  CG30025 MLKFVILLSAVACALGGTVPEGLLPQLDGRIVGGSATTISSFPWQISLQRSGSHSCGGSI ************************************************************ CG30028  YSSNVIVTAAHCLQSVSASVLQIRAGSSYWSSGGVTFSVSSFKNHEGYNANTMVNDIAII  CG12351  YSSNVIVTAAHCLQSVSASVLQIRAGSSYWSSGGVTFSVSSFKNHEGYNANTMVNDIAII  CG30031  YSSNVIVTAAHCLQSVSASVLQIRAGSSYWSSGGVTFSVSSFKNHEGYNANTMVNDIAII  CG30025 YSSNVIVTAAHCLQSVSASVLQIRAGSSYWSSGGVTFSVSSFKNHEGYNANTMVNDIAII ************************************************************ I. II.
CG30028 KINGALTFSSTIKAIGLASSNPANGAAASVSGWGTLSYGSSSIPSQLQYVNVNIVSQSQC CG12351 KINGALTFSSTIKAIGLASSNPANGAAASVSGWGTLSYGSSSIPSQLQYVNVNIVSQSQC CG30031 KINGALTFSSTIKAIGLASSNPANGAAASVSGWGTLSYGSSSIPSQLQYVNVNIVSQSQC CG30025 KINGALTFSSTIKAIGLASSNPANGAAASVSGWGTLSYGSSSIPSQLQYVNVNIVSQSQC ************************************************************ Cross-talk of the proteasome with serine proteases CG12351 ASSTYGYGSQIRSTMICAAASGKDACQGDSGGPLVSGGVLVGVVSWGYGCAYSNYPGVYA CG30031 ASSTYGYGSQIRSTMICAAASGKDACQGDSGGPLVSGGVLVGVVSWGYGCAYSNYPGVYA CG30025 ASSTYGYGSQIRSTMICAAASGKDACQGDSGGPLVSGGVLVGVVSWGYGCAYSNYPGVYA ************************************************************ III .  CG30028  DVAALRSWVISNA  CG12351  DVAALRSWVISNA  CG30031  DVAALRSWVISNA  CG30025 DVAALRSWVINNA **********.** Transcript:
--ATTGGATTCGCACCATGCTGAAGTTCGTGATCTTGTTGTCTGCAGTAGCCTGCGCCCT ********************************************************** CG30028 GGGAGGCACCGTCCCTGAGGGACTCCTGCCTCAGTTGGATGGCCGCATTGTCGGCGGCTC CG12351 GGGAGGCACCGTCCCTGAGGGACTCCTGCCTCAGTTGGATGGCCGCATTGTCGGCGGCTC CG30031 GGGAGGCACCGTCCCTGAGGGACTCCTGCCTCAGTTGGATGGCCGCATTGTCGGCGGCTC CG30025 GGGAGGCACCGTCCCTGAGGGACTCCTGCCTCAGTTGGATGGCCGCATTGTCGGCGGCTC ************************************************************ CG30028 TGCTACCACCATCAGCAGCTTCCCCTGGCAGATCTCCCTGCAGCGCAGTGGAAGCCACTC CG12351 TGCTACCACCATCAGCAGCTTCCCCTGGCAGATCTCCCTGCAGCGCAGTGGAAGCCACTC CG30031 TGCTACCACCATCAGCAGCTTCCCCTGGCAGATCTCCCTGCAGCGCAGTGGAAGCCACTC CG30025 TGCTACCACCATCAGCAGCTTCCCCTGGCAGATCTCCCTGCAGCGCAGTGGAAGCCACTC ************************************************************ CG30028 CTGCGGTGGATCCATCTACTCCAGCAACGTCATCGTGACCGCCGCTCACTGTCTGCAGTC CG12351 CTGCGGTGGATCCATCTACTCCAGCAACGTCATCGTGACCGCCGCTCACTGTCTGCAGTC CG30031 CTGCGGTGGATCCATCTACTCCAGCAACGTCATCGTGACCGCCGCTCACTGTCTGCAGTC CG30025 CTGCGGTGGATCCATCTACTCCAGCAACGTCATCGTGACCGCCGCTCACTGTCTGCAGTC ************************************************************ CG30028 CGTGTCCGCTTCCGTCCTGCAGATCCGTGCTGGATCCAGCTACTGGAGCTCCGGCGGTGT CG12351 CGTGTCCGCTTCCGTCCTGCAGATCCGTGCTGGATCCAGCTACTGGAGCTCCGGCGGTGT CG30031 CGTGTCCGCTTCCGTCCTGCAGATCCGTGCTGGATCCAGCTACTGGAGCTCCGGCGGTGT CG30025 CGTGTCCGCTTCCGTCCTGCAGATCCGTGCTGGATCCAGCTACTGGAGCTCCGGCGGTGT ************************************************************ CG30028 CACCTTCTCTGTGTCCTCCTTCAAGAACCACGAGGGCTACAACGCCAACACCATGGTCAA CG12351 CACCTTCTCTGTGTCCTCCTTCAAGAACCACGAGGGCTACAACGCCAACACCATGGTCAA CG30031 CACCTTCTCTGTGTCCTCCTTCAAGAACCACGAGGGCTACAACGCCAACACCATGGTCAA CG30025 CACCTTCTCTGTGTCCTCCTTCAAGAACCACGAGGGCTACAACGCCAACACCATGGTCAA ************************************************************ CG30028 CGACATTGCCATCATCAAGATCAACGGCGCCCTGACCTTCAGCTCCACCATCAAGGCCAT CG12351 CGACATTGCCATCATCAAGATCAACGGCGCCCTGACCTTCAGCTCCACCATCAAGGCCAT CG30031 CGACATTGCCATCATCAAGATCAACGGCGCCCTGACCTTCAGCTCCACCATCAAGGCCAT CG30025 CGACATTGCCATCATCAAGATCAACGGCGCCCTGACCTTCAGCTCCACCATCAAGGCCAT ************************************************************ CG30028 CGGTCTGGCTAGCTCCAACCCCGCCAACGGCGCTGCGGCCTCCGTCTCCGGATGGGGCAC CG12351 CGGTCTGGCTAGCTCCAACCCCGCCAACGGCGCTGCGGCCTCCGTCTCCGGATGGGGCAC CG30031 CGGTCTGGCTAGCTCCAACCCCGCCAACGGCGCTGCGGCCTCCGTCTCCGGATGGGGCAC CG30028 ASSTYGYGSQIRSTMICAAASGKDACQGDSGGPLVSGGVLVGVVSWGYGCAYSNYPGVYA CG30025 CGGTCTGGCTAGCTCCAACCCCGCCAACGGCGCTGCGGCCTCCGTCTCCGGATGGGGCAC ************************************************************ CG30028  TCTCTCCTACGGATCCAGCTCCATCCCCTCCCAGCTGCAGTACGTGAACGTGAACATCGT  CG12351  TCTCTCCTACGGATCCAGCTCCATCCCCTCCCAGCTGCAGTACGTGAACGTGAACATCGT  CG30031  TCTCTCCTACGGATCCAGCTCCATCCCCTCCCAGCTGCAGTACGTGAACGTGAACATCGT  CG30025 TCTCTCCTACGGATCCAGCTCCATCCCCTCCCAGCTGCAGTACGTGAACGTGAACATCGT ************************************************************ CG30028  TAGCCAGAGCCAGTGTGCTTCCTCCACCTACGGATACGGTAGCCAGATCCGCAGCACCAT  CG12351  TAGCCAGAGCCAGTGTGCTTCCTCCACCTACGGATACGGTAGCCAGATCCGCAGCACCAT  CG30031  TAGCCAGAGCCAGTGTGCTTCCTCCACCTACGGATACGGTAGCCAGATCCGCAGCACCAT  CG30025 TAGCCAGAGCCAGTGTGCTTCCTCCACCTACGGATACGGTAGCCAGATCCGCAGCACCAT ************************************************************ CG30028 GATCTGCGCTGCTGCCAGCGGCAAGGATGCCTGCCAGGGTGACTCCGGTGGCCCACTGGT CG12351 GATCTGCGCTGCTGCCAGCGGCAAGGATGCCTGCCAGGGTGACTCCGGTGGCCCACTGGT CG30031 GATCTGCGCTGCTGCCAGCGGCAAGGATGCCTGCCAGGGTGACTCCGGTGGCCCACTGGT CG30025 GATCTGCGCTGCTGCCAGCGGCAAGGATGCCTGCCAGGGTGACTCCGGTGGCCCACTGGT ************************************************************ CG30028 CTCCGGCGGAGTCCTCGTCGGTGTTGTCTCCTGGGGATACGGATGCGCTTACTCCAACTA CG12351 CTCCGGCGGAGTCCTCGTCGGTGTTGTCTCCTGGGGATACGGATGCGCTTACTCCAACTA CG30031 CTCCGGCGGAGTCCTCGTCGGTGTTGTCTCCTGGGGATACGGATGCGCTTACTCCAACTA CG30025 CTCCGGCGGAGTCCTCGTCGGTGTTGTCTCCTGGGGATACGGATGCGCTTACTCCAACTA ************************************************************ CG30028 CCCCGGTGTCTATGCCGATGTTGCTGCCCTCCGCTCCTGGGTTATTAGCAATGCCTAAGA CG12351 CCCCGGTGTCTATGCCGATGTTGCTGCCCTCCGCTCCTGGGTTATTAGCAATGCCTAAAA CG30031 CCCCGGTGTCTATGCCGATGTTGCTGCCCTCCGCTCCTGGGTTATTAGCAATGCCTAAGA CG30025 CCCCGGTGTCTATGCCGATGTTGCTGCCCTCCGCTCCTGGGTGATCAACAACGCCTAATT ****************************************** ** *.*** ****** :
AGTATGCGAAATAAATT-TCAGTTTGGATATT CG30025 ATTTTTCGAAATAAATCATATATGAACAGTTT * * * *********: *.:.* * ::* Cross-talk of the proteasome with serine proteases 
